Literature DB >> 8359765

A treatment algorithm for neuropathic (Charcot) midfoot deformity.

M S Pinzur1, R Sage, R Stuck, S Kaminsky, A Zmuda.   

Abstract

Forty-nine feet in 47 patients with midfoot neuropathic foot deformity were referred for care to a comprehensive foot salvage clinic and followed for an average of 3.6 years. Twenty-three initially presented without open ulcers. Two underwent elective Syme's ankle disarticulation amputation, and the others were kept ambulatory with a combination of periods of nonweightbearing cast immobilization, accommodative extra-depth shoes with custom orthotics, and ankle-foot orthoses. Twenty-six of the feet initially presented for care with open ulcers and/or chronic osteomyelitis. Twenty-two of these patients underwent 32 surgical procedures. Sixteen underwent debridement of the infected bone and surrounding soft tissues. Excision of large, nonaccommodative boney prominence, termed exostectomy, was performed in eight. Partial excision of the deformed midfoot combined with boney stabilization and attempted arthrodesis, termed partial tarsectomy, were performed in seven. All surgical patients were managed postoperatively with long-term custom accommodative bracing. Follow-up at an average of 3.6 years revealed that all but one of the patients remained ambulatory. Six walk with accommodative shoe gear and persistent stable chronic open ulcers. None required below-knee amputation. Five amputations were performed, three at the Syme's ankle disarticulation level, one at the Chopart's hind-foot level, and one at the mid-foot level.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8359765     DOI: 10.1177/107110079301400403

Source DB:  PubMed          Journal:  Foot Ankle        ISSN: 0198-0211


  10 in total

1.  Charcot foot reconstruction with combined internal and external fixation: case report.

Authors:  Claire M Capobianco; Crystal L Ramanujam; Thomas Zgonis
Journal:  J Orthop Surg Res       Date:  2010-02-11       Impact factor: 2.359

2.  [The Midfoot Fusion Bolt: a new perspective?].

Authors:  M Wurm; R Schuh; A Wanivenhaus; R Windhager; H-J Trnka
Journal:  Orthopade       Date:  2015-01       Impact factor: 1.087

3.  Salvage of Chronic Therapy-Resistant Bilateral Charcot Foot Osteoarthropathy with Signs of Osteomyelitis.

Authors:  Ariel Kidron; Hiep H Nguyen; Jack Bayer; Michael Durkin; Daniel Harris; Helen Dang; Matt Diehl; Larry Silver
Journal:  Orthop Surg       Date:  2022-05-19       Impact factor: 2.279

4.  A case of diabetic Charcot arthropathy of the foot and ankle.

Authors:  John M Embil; Elly Trepman
Journal:  Nat Rev Endocrinol       Date:  2009-10       Impact factor: 43.330

5.  Surgical OFF-LOADING of the diabetic foot.

Authors:  Luca Dalla Paola; Anna Carone; Marialuisa Valente; Mariano Palena; Giuseppe Scavone
Journal:  J Clin Orthop Trauma       Date:  2021-01-22

6.  Charcot foot reconstruction outcomes: A systematic review.

Authors:  Joon Ha; Thomas Hester; Robert Foley; Ines L H Reichert; Prashanth R J Vas; Raju Ahluwalia; Venu Kavarthapu
Journal:  J Clin Orthop Trauma       Date:  2020-04-20

7.  Distally Based Pedicled Fibula Flap for Reconstruction of Infected Charcot's Midtarsal Collapse-Diabetic Rocker Bottom Foot.

Authors:  T M Balakrishnan; Sathya Pakkiri; Arounkumar Nagalingam; R Selvaraj; J Jaganmohan
Journal:  Indian J Plast Surg       Date:  2021-02-15

8.  Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?

Authors:  Rachel H Albright; Robert M Joseph; Dane K Wukich; David G Armstrong; Adam E Fleischer
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

9.  Conservative and surgical treatment of the chronic Charcot foot and ankle.

Authors:  Mehmet Fatih Güven; Atakan Karabiber; Gökhan Kaynak; Tahir Oğüt
Journal:  Diabet Foot Ankle       Date:  2013-08-02

Review 10.  Charcot foot and ankle with osteomyelitis.

Authors:  Ryan Donegan; Bauer Sumpio; Peter A Blume
Journal:  Diabet Foot Ankle       Date:  2013-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.